Attachment_Q_FY12_PEPFAR_ANNUAL_PROGRESS_REPORT_RESULTS.pdf

2013-02-01 16:01:37 EST

U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), Haiti

ANNUAL PROGRESS REPORT RESULTS DATA

FY2012

NATIONAL LEVEL INDICATOR RESULTS

National Reporting Time Frame does not exist for this Unit/Reporting Cycle.

Haiti

Care Indicator National Target

National Result

"Umbrella" Care Indicators

C1.1.N: Number of eligible adults and children provided with a minimum of one care service

Number of adults and children provided with a minimum of one care service

155000 180269

By Age: < 18 42000 48673

By Age: 18+ 113000 131596

Health Systems Strengthening Indicator National Target

National Result

Human Resources for Health

H2.1.N: Number of new health care workers who graduated from a pre-service training institution within the reporting period

A count of the number of new health care workers who graduated from a pre-service training institution or program

520 751

Prevention Indicator

Target

National Result

PMTCT

P1.1.N: Percent of pregnant women with known HIV status (includes women who were tested for HIV and received their results)

The number of women attending ANC, L&D, and postpartum services who were tested for HIV and received their results, and women with known HIV infection attending ANC for a new pregnancy in the last 12 months.

219704 198012

Estimated number of pregnant women in the last 12 months

274000 274000

P1.2.N: Percent of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission during pregnancy and delivery

Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission during pregnancy and delivery

4600 4911

Estimated number of pregnant women living with HIV needing antiretroviral medicine for preventing mother-to-child transmission based on UNAIDS/WHO methods

5200 5200

Treatment Indicator

Target

National Result

ARV Services

T1.2.N: Percent of adults and children with advanced HIV infection receiving antiretroviral therapy (ART)

Number of adults and children with advanced HIV infection who are currently receiving ART in accordance with the nationally approved treatment protocol (or WHO/UNAIDS standards) at the end of the reporting period

40400 41798

By Sex: Male 16476 16719

By Sex: Female 23924 25079

By Age: <15 2001 3762

By Age: 15+ 38399 38036

The estimated number of adults and children with advanced HIV infection (in need of ART)

57000 57000 kk

TECHNICAL AREA SUMMARY RESULTS

Haiti

Care Indicator

PEPFAR

Target

PEPFAR

Result

"Umbrella" Care Indicators

C1.1.D: Number of eligible adults and children provided with a minimum of one care service

Number of adults and children provided with a minimum of one care service

148000 127609

By Sex: Male 63000 0

By Sex: Female 85000 0

By Age: <18 40000 44376

By Age: 18+ 108000 83233

By Age/Sex: <18 Male - 0

By Age/Sex: 18+ Male - 0

By Age/Sex: <18 Female - 0

By Age/Sex: 18+ Female - 0

Clinical Care

C2.1.D: Number of HIV-positive adults and children receiving a minimum of one clinical service

Number of HIV-positive individuals receiving a minimum of one clinical service

91527 83959

By Age: 15+ 82527 76266

By Sex: Male 34025 34351

By Sex: Female 57502 49608

By Age: <15 9000 7693

By Age/Sex: <15 Male - 3616

By Age/Sex: 15+ Male - 30735

By Age/Sex: <15 Female - 4077

By Age/Sex: 15+ Female - 45531

C2.2.D: Percent of HIV-positive persons receiving Cotrimoxizole (CTX) prophylaxis

Number of HIV-positive persons receiving Cotrimoxizole (CTX) prophylaxis

77798 62978

Number of HIV-positive individuals receiving a minimum of one clinical service

91527 83959

C2.3.D: Number of HIV-positive clinically malnourished clients who received therapeutic or supplementary food

Number of clinically malnourished clients who received therapeutic and/or supplementary food during the reporting period.

4000 3265

C2.4.D: TB/HIV: Percent of HIV-positive patients who were screened for TB in HIV care or treatment setting

Number of HIV-positive patients who were screened for TB in HIV care or treatment setting

91527 83959

Number of HIV-positive individuals receiving a minimum

C2.5.D: TB/HIV: Percent of HIV-positive patients in HIV care or treatment (pre-ART or ART) who started TB treatment

Number of HIV-positive patients in HIV care who started TB treatment

2746 2233

Number of HIV-positive individuals receiving a minimum

Clinical/Prevention Services - Additional

Pediatric

C4.1.D: Percent of infants born to HIV-positive women who received an HIV test within 12 months of birth

Number of infants who received an HIV test within 12 months of birth during the reporting period

3341 3930

By timing and type of test: either virologically between 2 and 12 months or serology between 9 and 12 months

2673 2884

By timing and type of test: virological testing in the first 2 months

334 1704

Number of HIV- positive pregnant women identified in the reporting period (include known HIV- positive at entry)

6258 5824

Support Care

C5.1.D: Number of eligible clients who received food and/or other nutrition services

Number of adults and children who received food and/or nutrition services during the reporting period

40000 41062

By Age: <18 25000 0

By Age: 18+ 12000 0

By: Pregnant Women or Lactating Women 3000 0

Health Systems Strengthening Indicator

PEPFAR

Target

PEPFAR

Result

Human Resources H2.1.D: Number of new health care workers who graduated from a pre-service training for Health institution within the reporting period

Number of new health care workers who graduated from a pre-service training institution or program

750 751

By Cadre: Doctors 200 344

By Cadre: Nurses 300 385

By Cadre: Midwives 20 22

H2.2.D: Number of community health and para-social workers who successfully completed a pre-service training program

Number of community health and para-social workers who successfully completed a pre-service training program

2500 2354

H2.3.D: Number of health care workers who successfully completed an in-service training program within the reporting period

The number of health care workers who successfully completed an in-service training program

3000 2750

By Type of Training: Male Circumcision 0 0

By Type of Training: Pediatric Treatment 200 0

Laboratory

H1.1.D: Number of testing facilities (laboratories) with capacity to perform clinical laboratory tests

Number of testing facilities (laboratories) with capacity to perform clinical laboratory tests

139 122

H1.2.D: Percent of testing facilities (laboratories) that are accredited according to national or international standards

Number of testing facilities (laboratories) that are accredited according to national or international standards

0 0

Number of testing facilities (laboratories) with capacity to perform clinical laboratory tests

139 122

Prevention Indicator

Target

PEPFAR

Result

PMTCT

P1.1.D: Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results)

Number of pregnant women who were tested for HIV and know their results

211204 193544

P1.2.D: Number and percent of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission during pregnancy and delivery

Number of HIV-positive pregnant women who received antiretrovirals (ARVs) to reduce risk of mother-to-child-transmission

4380 4791

Single-dose nevirapine (with or without tail) 438 3

Maternal AZT (prophylaxis component of WHO Option A during pregnancy and deliverY)

0 26

Maternal triple ARV prophylaxis (prophylaxis component of WHO Option B during pregnancy and delivery)

1752 2419

Life-long ART (including Option B+) 2190 2065

Number of HIV- positive pregnant women identified in the reporting period (including known HIV- positive at entry)

6258 5824

Post-Exposure Prophylaxis

P6.1.D: Number of persons provided with post-exposure prophylaxis (PEP)

Number of persons provided with post-exposure prophylaxis (PEP) for risk of HIV infection through occupational and/or non-occupational exposure to HIV.

2882 1548

By Exposure Type: Other non-occupational 288 0

By Exposure Type: Rape/sexual assault victims 2162 1336

By Exposure Type: Occupational 432 212

Prevention for Positives (PwP)

P7.1.D: Number of People Living with HIV/AIDS (PLHIV) reached with a minimum package of 'Prevention with PLHIV (PLHIV) interventions

Number of People Living with HIV/AIDS reached with a minimum package of 'Prevention of People Living with HIV (PLHIV) interventions

Sexual and other Behavioral Risk

Prevention

P8.1.D: Number of the targeted population reached with individual and/or small group level HIV prevention interventions that are based on evidence and/or meet the minimum standards required

Number of the target population reached with individual and/or small group level HIV prevention interventions that are based on evidence and/or meet the minimum standards required

600000 173423

P8.2.D: Number of the targeted population reached with individual and/or small group level HIV prevention interventions that are primarily focused on abstinence and/or being faithful, and are based on evidence and/or meet the minimum standards required

Number of the target population reached with individual and/or small group level HIV prevention interventions that are primarily focused on abstinence and/or being faithful, and are based on evidence and/or meet the minimum standards required

150000 46531

P8.3.D: Number of MARP reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required

Number of MARP reached with individual and/or small group level preventive interventions that are based on evidence and/or meet the minimum standards required

89550 200216

By MARP Type: CSW 26250 112898

By MARP Type: IDU 0 0

By MARP Type: MSM 2500 1031

Other Vulnerable Populations 1100 86287

Testing and Counseling

P11.1.D: Number of individuals who received Testing and Counseling (T&C) services for HIV and received their test results

Number of individuals who received T&C services for HIV and received their test results during the past 12 months

589720 626088

By Sex: Male 219227 230803

By Sex: Female 370493 395285

By Age: <15 29486 31304

By Age: 15+ 560234 594784

By Age/Sex: <15 Male - 0

By Age/Sex: 15+ Male - 0

By Age/Sex: <15 Female - 0

By Age/Sex: 15+ Female - 0

Treatment Indicator

Target

PEPFAR

Result

ARV Services

T1.1.D: Number of adults and children with advanced HIV infection newly enrolled on

ART

Number of adults and children with advanced HIV infection newly enrolled on ART

10130 12557

By Age/Sex: <15 Female 331 325

By Age/Sex: <15 Male 299 280

By Age/Sex: 15+ Male 3830 4349

By Age/Sex: 15+ Female 5670 7603

By: Pregnant Women 2190 1161

By Age: <1 130 151

T1.2.D: Number of adults and children with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT]

Number of adults and children with advanced HIV infection receiving antiretroviral therapy (ART)

40000 41032

By Age/Sex: <15 Male 957 1071

By Age/Sex: 15+ Male 15320 14954

By Age/Sex: <15 Female 1044 1121

By Age/Sex: 15+ Female 22680 23886

By Age: <1 0 0

T1.3.D: Percent of adults and children known to be alive and on treatment 12 months after initiation of antiretroviral therapy

Number of adults and children who are still alive and on treatment at 12 months after initiating ART

8058 7012

By Age: <15 535 592

By Age: 15+ 10165 6420

Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up.

9630 8197